ICICI Securities Ltd | Retail Equity Research Revenues grew 8% YoY to | 3582 crore, (I-direct estimate: | 3670 crore) mainly due to growth in US and South Africa. US sales grew 33% to | 646 crore (I-direct estimate: | 625 crore) due to consolidation of InvaGen. Domestic formulations fell 4% to | 1197 crore (I-direct estimate: | 1346 crore) owing to changed distribution policy and supply side disruptions due to demonetisation EBITDA margins improved 882 bps YoY to 14.1% but below I-direct...